It has been demonstrated that IGF2BP2 is nearly always the most abundant IGF2BP paralogue in human cancers from the TCGA database [44] and was the only IGF2BP member whose expression correlated with late stage tumor growth in the current study. This evidence concerns the gene IGF2BP2 and cancer.